Dr. Johansen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2231 N High St
Columbus, OH 43201Phone+1 614-293-2700Fax+1 614-293-2720
Education & Training
University of MichiganResidency, Family Medicine, 2009 - 2011
Ohio State University HospitalInternship, Family Medicine, 2008 - 2009- Ohio State University College of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2008 - 2026
MI State Medical License 2009 - 2016- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 128 citationsGabapentinoid Use in the United States 2002 Through 2015.Michael E. Johansen
JAMA Internal Medicine. 2018-02-01 - 39 citationsAntiplatelet and Statin Use in US Patients With Coronary Artery Disease Categorized by Race/Ethnicity and Gender, 2003 to 2012.Michael E. Johansen, Jennifer L Hefner, Randi E. Foraker
The American Journal of Cardiology. 2015-06-01 - 4 citationsBenzodiazepine Use in the USA Is Driven by Long-term Users: a Repeated Cross-sectional Study of MEPS 2002–2016Michael E. Johansen, Joshua D. Niforatos
Journal of General Internal Medicine. 2019-05-01
Journal Articles
- Decreasing Use of Primary Care: A Repeated Cross-Sectional Study of MEPS 2007-2017Michael Johansen, MD, Annals of Family Medicine
- Trends in Total and Out-of-Pocket Expenditures for Visits to Primary Care Physicians, by Insurance Type, 2002-2017Michael Johansen, MD, Annals of Family Medicine
Authored Content
- Comparing Medical Ecology, Utilization, and Expenditures Between 1996–1997 and 2011–2012July 2017
Press Mentions
The Cardiovascular Outcomes, Heart Failure and Kidney Disease Trials Tell That the Time to Use Sodium Glucose Cotransporter 2 Inhibitors Is NowNovember 9th, 2020
Contacts with Primary Care Physicians Did Not Increase After the Affordable Care ActNovember 12th, 2019
Cutting Brand-Name Drug Use Could Save U.S. $73 Billion: StudyMay 10th, 2016- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
